A. Chan

Radiology, Nuclear Medicine and Imaging · Nature reviews. Immunology · 2002–2010

A researcher in the Science corpus: 4 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom A. Chan trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. R. Jefferis
  2. P. Carter
  3. Brian Kelley
  4. W. Sandborn

Who trusts A. Chan overall

  1. C. Deutschman
  2. Chia Chiu Lim

Papers from A. Chan's perspective

Ordered by how strongly the researchers A. Chan trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. (Blood)
  2. Potent antibody therapeutics by design (Nature reviews. Immunology)
  3. Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. (Journal of Clinical Oncology)
  4. Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody (Science)
  5. Engineered antibody Fc variants with enhanced effector function.
  6. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. (New England Journal of Medicine)
  7. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. (Gastroenterology)
  8. Antibody pharmacokinetics and pharmacodynamics. (Journal of Pharmacy and Science)
  9. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. (New England Journal of Medicine)
  10. The Impact of PEGylation on Biological Therapies (BioDrugs)

Their papers